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Abstract: A new proprietary herbomineral formulation was formulated, consisting of essential ingredients viz. herbal root 
extract ashwagandha and minerals (zinc, magnesium, and selenium). The aim of the study was to evaluate the 
immunomodulatory potential of Consciousness Energy Healing Treatment on the herbomineral formulation in male Sprague 
Dawley rats. The test formulation was divided into two parts. One part was denoted as the control without any Biofield Energy 
Treatment, while the other part was defined as the Biofield Energy Treated sample, which received the Biofield Energy 
Healing Treatment remotely from seven renowned Biofield Energy Healers. Additionally, one group of animals also received 
Biofield Energy Treatment per se (day -15) by Biofield Energy Healers under similar conditions. The test formulation was 
evaluated for immunological parameters viz. humoral immune analysis, paw volume, hematological study, biochemistry, body 
weight, feed and water intake, and histopathology analysis were performed. The humoral immune response showed a 
significant increased primary and secondary antibody titre values by 26% and 150.4%, respectively in Biofield Energy 
Treatment per se group (G6, day -15), while primary and secondary antibody titre values were increased by 100.0% and 
110.4%, respectively in the Biofield Energy Treated test formulation (G7, day -15) group compared with the disease control 
group (G2). The results of delayed type hypersensitivity showed a significant increase in the paw volume by 94.44% in the 
Biofield Energy Treated test formulation (G4) group with respect to the G2 group. However, a significant increase in paw 
volume by 61.11% and 44.44% was found in G6 and G7 group, respectively with respect to the G2 group. Hematological 
parameters showed a significant (p<0.001) increased platelet count by 85.6% in the G4 group, while 39.15% and 35.22% 
increase in the G6 and G7 groups, respectively compared with the G2 group. In biochemical analysis, a significant increase in 
calcium and phosphorus level were found in the G4 group compared with the G2 group. Animal weight parameters suggests 
that there were no treatment-related changes in any group, organ to body weight ratio, feed and water intake. The data 
described that the Biofield Energy Treated test formulation was found to be safe without any side effect during the course of 
the experiment. These data suggests that the Biofield Energy Treated test formulation and Biofield Energy Treatment per se 
can be used for autoimmune and inflammatory diseases, enhancing stress management and prevention, and anti-aging by 
improving overall health. 
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1. Introduction 
In traditional system of medicine, herbal formulations have 
been widely used for modulating the immune system [1]. 
Several synthetic immunomodulatory agents are used for 
autoimmune diseases, anti-inflammatory disorders, and 
antiaging, but mostly associated with some adverse effect and 
drug interactions [2-4]. Herbal formulations are extensively 
used in the indigenous system of medicine with significant 
clinical outcomes due to its high safety, better therapeutic 
action and few associated side effects [5]. Polyherbal and 
herbomineral formulations are used and prescribed for many 
autoimmune and anti-inflammatory disorders. Medicinal plant 
and minerals (Herbomineral based therapy) are used in 
combination for many immunomodulatory action [6]. 
Additionally, holistic medicine/integrative medicine addresses 
not only entire body, but the mind and spirit as well. Most of 
the traditional medicines are derived from medicinal plants, 
minerals, and organic matter [7]. The biological activities of 
traditional medicines are due to its wide chemical diversity, 
structural complexity, and broad spectrum activities, which 
referred as an ideal candidates for new therapeutics 
formulation. According to World Health Organization (WHO), 
medicinal plants are the major target of most of the 
pharmaceutical companies for new formulations due to the 
presence of one or more active phytoconstituents [8]. 
With this aspect, the authors of this study used a 
herbomineral formulation as a basis to investigate ways to 
improve the immunomodulatory activity. The test 
formulation containing four components with the 
combination of the herbal root extract ashwagandha and three 
minerals viz. zinc, magnesium, and selenium. Each 
constituent of the test formulation is reported for important 
pharmacological activities, such as ashwagandha (Withania 
somnifera) that belongs to the family Solanaceae, commonly 
used as alternative therapies due to the presence of active 
molecules like withanolides [9]. Apart from its common 
attributes such as antibacterial, immunomodulatory and 
cancer or tumor treatment, many clinical and preclinical data 
have been available with respect to the immunomodulatory 
impact [10-11]. The importance of minerals such as 
selenium, zinc, and magnesium to modulate the immune 
system has been well-defined [12]. 
The literature data found that the combination of minerals, 
herbal medicines exhibited a high level of phagocytic index 
and an improved antibody titre [13]. These herbomineral 
formulations can be used for better therapeutic effect in 
immune compromised patients that are affected by 
cardiovascular diseases, age, stress related diseases, cancer, 
and autoimmune disorders. Along with the herbomineral 
formulations, the Biofield Energy Healers in this study have 
used Consciousness Energy1 Healing Treatment (Biofield 
Energy Healing Treatment) as a complementary and 
alternative approach to study the impact of Biofield Energy 
Treatment on the herbomineral formulation for its 
immunomodulatory potential in male Sprague Dawley rats. 
In recent years, scientific reports and clinical trials on 
Biofield Energy Treatments showed the useful effects and 
enhanced immune function in cases of cervical cancer 
patients with therapeutic touch [14], massage therapy [15], 
etc. Amidst many Complementary and Alternative Medicine 
(CAM) therapies, there have been an extensive number of 
scientific reports showed that the Biofield Therapy (or 
Healing Modalities) as preferred models of treatment with 
several benefits to enhance physical, mental and emotional 
human wellness. The National Center of Complementary and 
Integrative Health (NCCIH) has recognized and accepted 
Biofield Energy Healing as a CAM health care approach in 
addition to other therapies, medicines and practices such as 
natural products, deep breathing, yoga, Tai Chi, Qi Gong, 
chiropractic/osteopathic manipulation, meditation, massage, 
special diets, homeopathy, progressive relaxation, guided 
imagery, acupressure, acupuncture, relaxation techniques, 
hypnotherapy, healing touch, movement therapy, pilates, 
Rolfing structural integration, mindfulness, Ayurvedic 
medicine, traditional Chinese herbs and medicines, 
naturopathy, essential oils, aromatherapy, Reiki, cranial 
sacral therapy. The Human Biofield Energy has subtle energy 
that has the capacity to work in an effective manner [16]. 
CAM therapies have been practiced worldwide with reported 
clinical benefits in different health disease profiles [17]. 
Biofield Energy Healing Treatment has gained rapid rapport 
as a holistic alternative and complementary medicine therapy 
that has significant impact on living organisms and nonliving 
materials without any adverse effects and in a manner that is 
more cost-effective than more conventional methods. 
Biofield Energy Treatment (The Trivedi Effect
®
) results has 
been published in numerous peer-reviewed science journals 
with significant outcomes in many scientific fields such as 
cancer research [18], microbiology [19-21], biotechnology 
[22], genetics [23, 24], pharmaceutics [25, 26], nutraceuticals 
[27], organic compounds [28, 29], agricultural science [30-
32], and changing the structure of the atom in relation to 
various metals, ceramics, polymers and chemicals in 
materials science [33-35]. 
In this study, the authors sought to explore the impact of 
the Biofield Energy Treatment (The Trivedi Effect
®
) on the 
given herbomineral formulation and Biofield Energy 
Treatment per se to the animals, which might improve the 
immunomodulatory function with respect to the antibody 
titre, delayed type hypersensitivity reaction, body weight 
change, feed consumption, hematological parameters, and 
serum biochemistry using standard assays. 
2. Materials and Methods 
2.1. Chemicals and Reagents 
Cyclophosphamide and carboxymethyl cellulose sodium 
were purchased from Sigma Chemical Co. (St. Louis, MO). 
Withania somnifera (Ashwagandha) root extract powder 
(≥5% of total withanolides) was procured from Sanat 
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Products Ltd., India. Zinc chloride and magnesium (II) 
gluconate hydrate were procured from TCI, Japan. Sodium 
selenate was procured from Alfa Aesar, USA. Levamisole 
hydrochloride was procured from Sigma, USA. All other 
chemicals used were of analytical grade available in India. 
2.2. Laboratory Animals 
A total number of 56 healthy male Sprague Dawley rats, 
weighing between 220-250 grams, were used for the study 
(n=8, in each group). The animals were purchased from M/s. 
Vivo Bio Tech Ltd., Hyderabad, India. Standard rodent diet 
was procured from M/s. Golden feeds, Mehrauli, New Delhi, 
India and provided ad libitum to all the groups of animals 
during the experiment under controlled conditions with a 
temperature of 22 ± 3°C, humidity of 30% to 70% and a 12-
hour light/12-hour dark cycle. The animals were acclimatized 
for 5 days prior to the experiment, and all were accessed once 
daily for clinical signs, behaviors, morbidity and mortality. All 
the procedures were in strict accordance with the Guide for the 
Care and Use of Laboratory Animals published by the US 
National Institutes of Health. The approval of the Institutional 
Animal Ethics Committee (IAEC/35/372 & 374) that was 
obtained prior to carrying out the animal experiment. 
2.3. Energy of Consciousness Treatment Strategies 
The test formulation was divided into two parts. One part 
of the test formulation was treated with the Biofield Energy 
by renowned Biofield Energy Healers (also known as The 
Trivedi Effect
®
) and coded as the Biofield Energy Treated 
formulation, while the second part of the test formulation did 
not receive any sort of treatment and was defined as the 
untreated test formulation. The Trivedi Effect
®
- Energy of 
Consciousness Healing Treatment (Biofield Energy Healing 
Treatment) was provided through a group of seven Biofield 
Energy Healers who participated in this study and performed 
the Biofield Energy Treatment remotely. Six Biofield Energy 
Healers were remotely located in the U.S.A. and one was 
located in Canada, while the test herbomineral formulation 
was located in the research laboratory of Dabur Research 
Foundation, New Delhi, India. Additionally, one group of 
animals also received the Biofield Energy Treatment per se 
by the Biofield Energy Healers under similar conditions. This 
Biofield Energy Treatment was administered for 5 minutes 
through the Healer’s unique Energy Transmission process 
remotely to the test formulation under laboratory conditions. 
None of the Biofield Energy Healers in this study visited the 
laboratory in person, nor had any contact with the 
herbomineral samples. Further, the control group was treated 
with a “sham” healer for comparative purpose. The sham 
healer did not have any knowledge about the Biofield Energy 
Treatment. After that, the Biofield Energy treated and 
untreated samples were kept in similar sealed conditions and 
used for identification of immunological parameters. 
2.4. Antigen (Sheep RBC) 
The fresh sheep blood was collected aseptically from the 
jugular vein of a healthy sheep and transferred immediately 
to the heparinized tube. The collected erythrocytes were 
separated from plasma by centrifugation (400 g, 10ºC, 10 
minutes), washed twice with the normal saline and then 
further diluted in saline, which were analyzed using 
Hematology analyzer (Abbott Model-CD-3700). Based on 
the number of erythrocytes, the samples were further diluted 
(using saline) before injecting to the rats [36]. 
2.5. Treatment Regimen 
After seven days of acclimatization, the animals were 
grouped based on the body weight. A total of seven groups 
(G) were included i.e. G1 to G7 with eight animals (n=8) in 
each group. The animals were received cyclophosphamide in 
all the groups except G1 at a dose of 10 mg/kg in normal 
saline through intraperitoneal (i.p.) route 1 hour before 
administration of the test formulation, from day 1 to 13. 
However, G1, G2, and G6 group’s animals were administered 
with vehicle (0.5% carboxy methyl cellulose-sodium salt) via 
oral gavage. G3 group animals received reference item, 
levamisole at a dose of 75 mg/kg body weight. G4 group 
animals received Biofield Energy Treated test formulation 
(1105.005 mg/kg b.wt, p.o.), and G5 animals received the 
untreated test formulation at the same dose by oral route. 
Further, G6 group animals received Biofield Energy 
Treatment per se at day -15, without test formulation, while 
G7 group animals received Biofield Energy Treated test 
formulation at day -15. The freshly prepared suspensions of 
the Biofield Energy Treated and untreated test formulations 
were administered orally to the G4 and G5 groups, 
respectively at a dose of 1105.005 mg/kg from day 1 to day 
25. However, Biofield Energy Treated test formulation was 
administered orally to the G7 group at same dose from day -
15 to day 25. The treatment was continued to all the tested 
groups (G1 to G7) with 5 mL/kg body weight dose volume. 
However, all the animals (G1-G7) were challenged with 
sheep red blood cells (sRBC) (0.5 x 10
9
/100 gm; i.p.) on day 7 
and 13, as the antigenic material to sensitize them for 
immunological studies. On day 13
th
 and 20
th
 the animals were 
bled and the samples were subjected to hemagglutination test 
for humoral immune response. On same day 20
th
, the animals 
were challenged with sRBC (0.5 x 10
9
 cells/50µL/rat) in sub-
planter region and on day 21
st
 (24 hours) paw volume was 
measured to evaluate the cellular immune response. The body 
weight and food consumption were measured daily before 
treatment. The animals were kept on overnight fasting on day 
24, followed by blood collection from retro-orbital plexus 
under isoflurane anaesthesia and the samples were subjected 
for haematology analysis and serum for biochemistry. At the 
end of the study, animals were euthanized by CO2 
asphyxiation as per in-house approved standard protocol. 
Different organs of all animals were excised, weighed and 
preserved for histopathological analysis. 
2.6. Determination of Humoral Immune Response 
On day 13 and 20, blood was withdrawn from the retro-
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orbital plexus of all antigenically challenged rats. 
Approximately 25 µL of serum was serially diluted with the 
25 µL of phosphate-buffered saline. The sRBC (0.025 x 10
9
 
cells) was added to each of these dilutions and incubated at 
37
º
C for 1 hour. The rank of minimum dilution that exhibited 
hemagglutination was considered as an antibody titre. The 
level of antibody titre on day 13
th
 of the experiment was 
considered as the primary humoral immune response, while 
antibody titre on day 20
th
 was considered as the secondary 
humoral immune response [37]. 
2.7. Determination of Paw Volume (Delayed Type 
Hypersensitivity) 
The cellular immune response was assayed by the footpad 
reaction method. The edema was induced in the right paw of 
rats by injecting sRBC (0.025 x 10
9
 cells) in the sub-plantar 
region. The increase in the paw volume after 24 hours (on 
day 21) was assessed on digital plethysmometer (PanLab, 
Spain). The mean percentage change in paw volume was 
considered as delayed type of hypersensitivity and as an 
index of cell-mediated immunity. The volume of the left hind 
paw, injected similarly with phosphate-buffered saline, 
served as control. 
2.8. Determination of Hematological and Biochemical 
Parameters 
The blood was collected from the retro-orbital plexus 
using heparinized and non-heparinized capillary tubes. One 
portion of the blood (non-heparinized capillary tubes) was 
kept as such for the serum collection and stored for 
biochemical analysis. The other portion (heparinized tubes) 
was directly subjected for the estimation of various 
hematological parameters using standard instruments. The 
level of hemoglobin (Hb), red cell blood count (RBC), 
packed cell volume (PCV), mean corpuscular volume 
(MCV), mean corpuscular hemoglobin (MCH), mean 
corpuscular hemoglobin concentration (MCHC), red cell 
distribution width (RDW-CV), and platelets were analyzed 
with blood samples. Further, the levels of magnesium, blood 
urea, creatinine, uric acid, calcium, phosphorus, potassium, 
sodium, and chloride ions concentration were analyzed using 
a Hematology analyzer (Abbott Model-CD-3700) [38]. 
2.9. Determination of Body Weight and Feed Intake 
Body weight and feed consumption of all the animals in 
various experimental groups were measured daily. Briefly, 
the weight of the daily feed supply and the left-over feed by 
the following days were recorded and the difference was 
taken as the daily feed intake. The average of the feed intake 
was computed for every three days of the experimental 
period [39]. 
2.10. Clinical Sign and Symptoms 
The animal clinical signs and symptoms were evaluated 
once daily throughout the experiment in accordance with in-
house protocol [40] with slight modification. Animals found 
in a moribund condition or enduring signs of severe distress 
were humanely euthanized. Abnormal findings were 
recorded with the time of onset and disappearance. 
2.11. Measurement of Relative Organ Weight and 
Histopathology 
At the end of the experiment, rats were dissected and the 
whole liver, kidneys, hearts, spleens, lungs, and testis were 
excised, freed of fat, blotted with clean tissue paper, and then 
weighed. The organ to body weight ratio was determined by 
comparing the weight of each organ with the final body 
weight of each rat. Defined samples were placed in 10% 
neutral buffered formalin for histopathological examination. 
2.12. Statistical Analysis 
Data were expressed as mean ± standard error of mean 
(SEM) and were subjected to Student’s t-test. Statistical 
significance was considered at p≤0.05. 
3. Results and Discussion 
3.1. Effect of Test Formulation on Humoral Immune 
Response 
The effect of the test formulation on primary and 
secondary humoral titre values in animals is summarized in 
Table 1. The mean value of primary haemagglutination (HA) 
antibody titre in a disease control group was significantly 
(p≤0.001) decreased (00.50 ± 0.27) compared with the 
normal control (13.00 ± 2.10). However, the primary 
antibody titre was slightly increased (i.e. 00.88 ± 0.52) after 
administration of standard drug, levamisole (G3) with respect 
to the disease control (G2). The animals in the Biofield 
Energy Treated test formulation group (G4) showed a 
decreased value of primary antibody titre as 00.13 ± 0.13 
with respect to the disease control group (G2), while the 
primary antibody titre in the untreated test formulation group 
(G5) was 00.50 ± 0.50. The primary antibody titre was 00.63 
± 0.50 in the G6 group (Biofield Energy Treatment per se 
day -15) and found to be higher than the G2 group. Similarly, 
the primary antibody titre was significantly increased by 
100% (01.00 ± 0.53) in G7 group as compared with the G2 
group. Overall, the primary antibody titre was increased by 
76%, 26%, and 100% in the G3, G6 and G7 group, 
respectively while decreased by 74% in the G4 group 
compared with the disease control group (G2). 
Similarly, the secondary HA antibody titre in case of the 
reference, levamisole (G3) showed a higher titre as 03.50 ± 
1.18 compared with the disease control (01.25 ± 0.65). The 
mean value of secondary antibody titre in a disease control 
group was significantly (p≤0.001) decreased (1.25 ± 0.65) 
compared with the normal control (15.50 ± 2.87). However, 
G4 group showed a significant decrease in secondary titre by 
88.8% (00.14 ± 0.13) compared with the disease control 
group. The secondary antibody titre in untreated test 
formulation (G5) group, G6, and G7 were 01.63 ± 0.46, 
03.13 ± 1.16 and 02.63 ± 1.27, respectively. Overall, the 
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values of secondary antibody titre were increased by 180%, 
30.4%, 150.4%, and 110.4% in G3, G5, G6, and G7 group 
respectively, while decreased by 88.8% in the G4 group 
compared with the disease control group (G2). 
Table 1. Effect of the test formulation on humoral immune response in male 
rats. 
Group (G) Primary HA titre Secondary HA titre 
G1 13.00 ± 2.10 15.50 ± 2.87 
G2 00.50 ± 0.27*** 01.25 ± 0.65*** 
G3 00.88 ± 0.52 03.50 ± 1.18 
G4 00.13 ± 0.13 00.14 ± 0.13 
G5 00.50 ± 0.50 01.63 ± 0.46 
G6 00.63 ± 0.50 03.13 ± 1.16 
G7 01.00 ± 0.53 02.63 ± 1.27 
HA: Haemagglutination; G1: Normal Control; G2: Disease Control: G3: 
Levamisole; G4: Biofield Energy Treated test formulation; G5: Untreated 
test formulation; G6: Biofield Energy Treatment per se (day -15); G7: 
Biofield Energy Treated test formulation (day -15). All values are expressed 
as the mean ± SEM. ***p≤0.001 compared with the normal control (n = 8). 
These experimental findings provided a valuable 
information about the influence of Biofield Energy Healing 
Treatment on both the primary and secondary humoral 
immune responses in male rats. It is presumed that the 
Biofield Energy Treatment per se and Biofield Treated test 
formulation possess potential immunomodulatory activities. 
It can be assumed that the altered primary and secondary titre 
values in different groups with respect to disease control 
might be due to the T-cell-dependent antigen [41]. Further, 
the significant increase of the antibody titre in the Biofield 
Energy Treated test formulation, Biofield Energy Treatment 
per se (day -15), and the Biofield Energy Treated test 
formulation (day -15) clearly indicates significant modulation 
of the humoral immunity due to the Biofield Energy Healing. 
It might be expected that alteration in antibody titre might be 
due to the production of specific antibodies 
(immunoglobulins) by lymphatic or plasma cells after 
sensitization to the specific antigens [42]. Thus, Biofield 
Energy Healing Treatment on day -15 and after inducing the 
disease in different groups, which suggest a significant 
capacity to prevent the disease condition. However, the test 
formulation constituents such as ashwagandha and minerals 
might be responsible to increase the antibody titre values as 
reported in the scientific literature [43]. However, 
experimental data suggest that the Biofield Energy Treated 
test formulation (day -15) showed a better response 
compared with the G2, while Biofield Energy Treatment per 
se also showed a significant increase in the secondary 
antibody titre with respect to the other groups. 
3.2. Effect of the Test Formulation on Paw Volume 
(Delayed Type Hypersensitivity) 
With respect to the cellular immune response, levamisole 
treated group showed an increase in the paw volume (Figure 
1) along with all other groups such as G3, G4, G5, G6, and 
G7 compared with the disease control group (00.18 ± 0.04). 
The mean edema values in the G3, G4, G5, G6, and G7 
groups were 00.32 ± 0.06, 00.35 ± 0.08, 00.32 ± 0.04, 00.29 
± 0.08, and 00.26 ± 0.07 mL, respectively. However, the 
Biofield Energy Treated test formulation (G4) group showed 
a better response and significant increased paw volume by 
94.44% with respect to disease control group (G2). The 
Biofield Energy Treated test formulation (G7, day -15) and 
Biofield Energy Treatment per se (G6, day -15) showed an 
increased paw edema volume by 44.44% and 61.11%, 
respectively. This indicated that the Biofield Energy Treated 
test formulation and Biofield Energy Treatment per se (day -
15) were significantly effective with respect to the 
stimulation of secondary immune response. According to the 
scientific literature, ashwagandha was reported with an 
increased animal paw volume [43], while mineral complex 
such as zinc was also reported with an increased delayed type 
hypersensitivity reaction [44]. Thus, it can be concluded with 
the data, that the constituents present in the formulation are 
responsible for delayed type hyper sensitivity reaction, but 
Biofield Energy Treatment (The Trivedi Effect
®
) further 
enhanced the cellular immune response compared with the 
untreated test formulation. 
 
Figure 1. The effect of the test formulation on paw volume (delayed-type hypersensitivity) in male rats. G1: Normal Control; G2: Disease Control: G3: 
Levamisole; G4: Biofield Energy Treated test formulation; G5: Untreated test formulation; G6: Biofield Energy Treatment per se (day -15); G7: Biofield 
Energy Treated test formulation (day -15). All values are expressed as the mean ± SEM (n = 8). 
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3.3. Effect of the Test Formulation on Hematology 
Parameters 
The results of the hematology profile analysis after 
administration of test formulation in experimental animals 
showed a slight alterations but no statistical significant 
difference among different group with respect to the disease 
control (G2) group. The results of the hematology profile of all 
the groups are summarized in the Table 2. All the tested 
parameters such as RBC, Hb, PCV, MCV, MCH, and MCHC 
showed a non-significant alteration with respect to the normal 
and disease control group. The RBC count was slightly 
increased in the Biofield Energy Treatment group per se day -
15 (9.57 ± 0.19 10
6
/	L) and Biofield Energy Treated test 
formulation group day -15 (G7) group (9.42 ± 0.16) compared 
with the disease control group (8.94 ± 0.17). However, the 
Biofield Treated test formulation group (G4) showed a 
significant (p<0.001) increase in the platelet count i.e. 1009.67 
± 115.43 thousand/mm
3
 compared with the disease control 
group, 544.00 ± 77.92 thousand/mm
3
. Overall, the platelet 
count was increased by 85.60% in the G4 compared with the 
G2 group. However, other experimental groups such as 
untreated test formulation (G5), Biofield Energy Treatment per 
se group (G6, day -15) and Biofield Energy Treated test 
formulation (G7, day -15) showed an increase in the platelet 
count by 21.07%, 39.15%, and 35.22% respectively, compared 
with the disease control (G2). 
Table 2. Hematology profile after treatment with the test formulation in male rat. 
Group 
RBC 
106/	L 
Hb 
gm/dL 
PCV 
% 
MCV 
fl 
MCH 
pg 
MCHC 
% 
Platelet Count 
(thousand/mm3) 
RDW-CV 
G1 9.59 ± 0.15 15.99 ± 0.19 56.13 ± 1.26 58.61 ± 1.35 16.79 ± 0.37 28.74 ± 0.64 685.00 ± 117.94 0.14 ± 0.01 
G2 8.94 ± 0.17 15.38 ± 0.24 54.14 ± 1.75 60.59 ± 1.38 17.31 ± 0.18 28.75 ± 0.82 544.00 ± 77.92 0.15 ± 0.01 
G3 8.50 ± 0.13 14.48 ± 0.24 51.76 ± 1.27 60.96 ± 1.17 17.14 ± 0.16 28.26 ± 0.71 643.75 ± 94.22 0.15 ± 0.00 
G4 8.62 ± 0.47 15.78 ± 0.44 58.52 ± 1.78 64.13 ± 1.01 17.23 ± 0.30 26.93 ± 0.31 1009.67 ± 115.43*** 0.16 ± 0.00 
G5 9.72 ± 0.15 15.71 ± 0.16 58.88 ± 0.77 60.75 ± 1.41 16.14 ± 0.34 26.65 ± 0.14 658.63 ± 57.83 0.16 ± 0.00 
G6 9.57 ± 0.19 15.49 ± 0.20 58.90 ± 0.96 61.78 ± 1.61 16.16 ± 0.36 26.26 ± 0.12 757.00 ± 72.98 0.17 ± 0.00 
G7 9.42 ± 0.16 15.41 ± 0.40 57.05 ± 1.80 60.65 ± 1.67 16.31 ± 0.33 27.36 ± 0.26 735.63 ± 51.56 0.17 ± 0.00 
G1: Normal Control; G2: Disease Control: G3: Levamisole; G4: Biofield Energy Treated test formulation; G5: Untreated test formulation; G6: Biofield 
Energy Treatment per se (day -15); G7: Biofield Energy Treated test formulation (day -15). RBC: Red blood cells, Hb: Hemoglobin; PCV: Packed cell 
volume; MCV: Mean corpuscular volume; MCH: Mean corpuscular hemoglobin; MCHC: Mean corpuscular hemoglobin concentration; RDW-CV: Red cell 
distribution width - coefficient of variation. All values are expressed as the mean ± SEM. ***p<0.001 compared with the disease control, (n = 8). 
The test formulation showed an improved hematological 
profile, it might be due to the components of the test 
formulation such as ashwagandha, zinc, selenium, and 
magnesium, which might be responsible for a significant 
improved platelet count. Scientific literature reported that 
ashwagandha treatment in mice increases the platelet count, 
red blood cell, white blood cell and hemoglobin 
concentration [45, 46]. In addition, ashwagandha root extract 
was non-toxic to the human erythrocytes [47]. The current 
findings showed no hemolysis at different tested 
concentrations of test herbomineral formulation. Further, it 
was also reported that selenium is significantly associated 
with an improved platelet count [48]. However, the zinc and 
magnesium present in the test formulation were also reported 
to be safe, important, and have good therapeutic action [49]. 
Our experimental results can be well collaborated with the 
existing literature results, significant improved blood profile 
might be due to the presence of components present in the 
test formulation. However, Biofield Energy Healing 
Treatment significantly increased the hematological profile in 
Biofield Energy Treated test formulation group compared 
with the untreated test formulation. Thus, it can be concluded 
that The Trivedi Effect
®
- Energy of Consciousness Healing 
Treatment (Biofield Energy Healing Treatment) has the 
significant capacity to improve the blood profile and can be 
used against many blood related autoimmune disorders, anti-
inflammatory diseases and antiaging. 
3.4. Effect of the Test Formulation on Biochemical 
Parameters 
The serum biochemical parameters were examined after 
treatment with the test formulation in different tested groups 
such as the level of magnesium, blood urea, creatinine, uric 
acid, calcium, phosphorus, potassium, sodium, and chloride 
ion concentrations (Table 3). Among the tested ions, no 
significant change was observed in magnesium, creatinine, 
potassium, sodium and chloride levels in the tested groups 
compared with the disease control group. In case of blood 
urea and uric acid, the level was increased in all the tested 
group with respect to the disease control group. Besides, the 
level of calcium was reported to be slight increased as 12.23 
± 0.23, 12.14 ± 0.24, 12.38 ± 0.17, and 12.75 ± 0.11 mg/dL 
in the G4, G5, G6, and G7 groups respectively, compared 
with the disease control group (G2), 11.83 ± 0.09 mg/dL. 
Similar increased pattern was also reported in the phosphorus 
levels, i.e. 10.72 ± 0.48, 10.88 ± 0.25, 11.19 ± 0.23, and 
11.30 ± 0.29 mg/dL in the G4, G5, G6, and G7 groups 
respectively, compared with the G2 group, 10.60 ± 0.60 
mg/dL. Overall, the Biofield Energy Treated test formulation 
(G4) group showed an increase calcium and phosphorus 
levels by 3.38% and 1.13% respectively, while the Biofield 
Energy Treatment per se group (G6, day -15) showed an 
increased calcium and phosphorus levels by 4.65% and 
5.67%, respectively compared with the disease control group. 
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However, overall result suggested that the change in 
biochemical parameters after administration of test 
formulation did not showed any significant alterations 
compared with the disease control group. 
Table 3. Effect of the test formulation on biochemical parameters in male rat. 
Group 
Magnesium 
(mg/dL) 
Blood Urea 
(mg/dL) 
Creatinine 
(mg/dL) 
Uric Acid 
(mg/dL) 
Calcium 
(mg/dL) 
Phosphorus 
(mg/dL) 
K+ (mEq/l) 
Na+ 
(Meq/l) 
Cl- (mEq/l) 
G1 8.71 ± 0.62 37.79 ± 1.84 0.26 ± 0.03 0.91 ± 0.13 11.61 ± 0.17 9.48 ± 0.26 146.66 ± 0.94 4.65 ± 0.08 106.75 ± 1.06 
G2 9.25 ± 0.06 39.23 ± 1.52 0.28 ± 0.02 0.90 ± 0.11 11.83 ± 0.09 10.60 ± 0.60 148.01 ± 0.95 4.93 ± 0.09 104.50 ± 1.94 
G3 9.13 ± 0.06 57.41 ± 3.48 0.37 ± 0.02 1.28 ± 0.13 12.35 ± 0.13 10.96 ± 0.27 146.49 ± 1.09 4.90 ± 0.11 102.63 ± 1.12 
G4 9.13 ± 0.12 53.18 ± 3.40 0.30 ± 0.00 2.13 ± 0.42 12.23 ± 0.23 10.72 ± 0.48 146.78 ± 1.29 4.67 ± 0.15 103.00 ± 1.03 
G5 9.18 ± 0.02 51.20 ± 3.95 0.31 ± 0.02 1.41 ± 0.15 12.14 ± 0.24 10.88 ± 0.25 147.98 ± 1.18 4.98 ± 0.06 102.75 ± 1.78 
G6 9.15 ± 0.04 58.05 ± 2.15 0.30 ± 0.02 1.83 ± 0.17 12.38 ± 0.17 11.19 ± 0.23 146.34 ± 1.00 4.70 ± 0.10 103.38 ± 1.76 
G7 9.13 ± 0.04 66.59 ± 3.02 0.34 ± 0.03 2.20 ± 0.19 12.75 ± 0.11 11.30 ± 0.29 146.91 ± 0.85 4.99 ± 0.11 104.75 ± 1.24 
G1: Normal Control; G2: Disease Control: G3: Levamisole; G4: Biofield Energy Treated test formulation; G5: Untreated test formulation; G6: Biofield 
Energy Treatment per se (day -15); G7: Biofield Energy Treated test formulation (day -15). All values are expressed as the mean ± SEM (n=8). 
3.5. Effect of the Test Formulation on Animal Weight 
Parameters 
The animal weight parameters such as body weight and the 
organ weight were compared with their respective initial 
mean animal body weight of rats after administration of test 
formulation (Table 4). The data showed the final body 
weights was increased with difference in the mean body 
weight from group G1 to G7. However, the final body weight 
in all the groups were changed but not significant with 
normal increase pattern, which suggests that the Biofield 
Energy Treated herbomineral formulation was found to be 
safe. Similarly, no significant change was observed in the 
tested organ weight throughout the experiment in terms of 
percentage relative organ weight of liver, lungs, kidney, 
brain, heart, eye, spleen, duodenum, jejunum, ileum, caecum, 
colon, rectum, testis, prostate, epididymis, vas deference, and 
pancreas with respect to the normal control throughout the 
exposure period. The relative organ weight in all the groups 
did not cause any significant alteration, it suggest that the 
Biofield Energy Treated test formulation and Biofield Energy 
Treatment per se (day -15) were found to be safe and non-
toxic at all the tested concentrations. 
Table 4. Effect of the test formulation on weight parameters in male rats. 
Relative weight (%) G1 G2 G3 G4 G5 G6 G7 
Liver 3.62 ± 0.09 3.92 ± 0.04 5.11 ± 0.13 3.85 ± 0.18 4.33 ± 0.06 3.98 ± 0.12 4.25 ± 0.11 
Lungs 0.89 ± 0.06 1.19 ± 0.06 1.05 ± 0.07 0.72 ± 0.09 0.78 ± 0.06 0.79 ± 0.05 0.94 ± 0.11 
Kidney 0.86 ± 0.02 0.97 ± 0.02 1.06 ± 0.03 0.72 ± 0.04 0.87 ± 0.04 0.86 ± 0.03 0.86 ± 0.03 
Brain 0.57 ± 0.02 0.43 ± 0.02 0.62 ± 0.02 0.52 ± 0.02 0.60 ± 0.02 0.59 ± 0.02 0.60 ± 0.03 
Heart 0.40 ± 0.02 0.43 ± 0.04 0.42 ± 0.03 0.34 ± 0.02 0.40 ± 0.01 0.39 ± 0.02 0.40 ± 0.02 
Eyes 0.09 ± 0.01 0.09 ± 0.01 0.10 ± 0.01 0.09 ± 0.01 0.09 ± 0.01 0.09 ± 0.01 0.09 ± 0.01 
Spleen 0.26 ± 0.01 0.30 ± 0.01 0.23 ± 0.01 0.18 ± 0.01 0.22 ± 0.01 0.22 ± 0.01 0.22 ± 0.01 
Duodenum 0.28 ± 0.05 0.30 ± 0.02 0.36 ± 0.04 0.29 ± 0.04 0.36 ± 0.02 0.29 ± 0.03 0.37 ± 0.05 
Jejunum 2.02 ± 0.17 2.10 ± 0.08 2.21 ± 0.10 2.07 ± 0.20 2.45 ± 0.15 2.06 ± 0.08 2.34 ± 0.13 
Ileum 0.29 ± 0.05 0.57 ± 0.02 0.33 ± 0.02 0.25 ± 0.20 0.35 ± 0.03 0.34 ± 0.04 0.31 ± 0.03 
Caecum 0.59 ± 0.04 0.35 ± 0.04 0.59 ± 0.04 0.54 ± 0.04 0.59 ± 0.04 0.56 ± 0.07 0.58 ± 0.03 
Colon 0.33 ± 0.02 0.15 ± 0.03 0.41 ± 0.03 0.28 ± 0.04 0.32 ± 0.02 0.31 ± 0.02 0.32 ± 0.03 
Rectum 0.19 ± 0.02 0.15 ± 0.02 0.21 ± 0.03 0.15 ± 0.02 0.16 ± 0.01 0.18 ± 0.01 0.17 ± 0.01 
Testis 0.96 ± 0.02 0.99 ± 0.05 1.03 ± 0.03 0.91 ± 0.04 0.99 ± 0.02 0.98 ± 0.02 1.01 ± 0.06 
Prostrate 0.28 ± 0.01 0.41 ± 0.02 0.26 ± 0.02 0.23 ± 0.03 0.27 ± 0.02 0.30 ± 0.03 0.26 ± 0.01 
Epididymis 0.39 ± 0.02 0.41 ± 0.02 0.41 ± 0.01 0.36 ± 0.01 0.46 ± 0.02 0.41 ± 0.02 0.42 ± 0.03 
Vas deference 0.10 ± 0.01 0.09 ± 0.01 0.09 ± 0.01 0.08 ± 0.00 0.09 ± 0.01 0.08 ± 0.01 0.09 ± 0.01 
Pancreas 0.48 ± 0.02 0.45 ± 0.03 0.63 ± 0.06 0.43 ± 0.07 0.54 ± 0.06 0.51 ± 0.07 0.59 ± 0.05 
G1: Normal Control; G2: Disease Control: G3: Levamisole; G4: Biofield Energy Treated test formulation; G5: Untreated test formulation; G6: Biofield 
Energy Treatment per se (day -15); G7: Biofield Energy Treated test formulation (day -15). All values are expressed as the mean ± SEM (n = 8). 
Similarly, no significant change was observed in the tested 
organ weight throughout the experiment in terms of 
percentage relative organ weight of liver, lungs, kidney, 
brain, heart, eyes, spleen, duodenum, jejunum, ileum, 
caecum, colon, rectum, testis, prostate, epididymis, vas 
deference, and pancreas with respect to normal control 
throughout the exposure period. The relative organ weight in 
all the groups did not show any significant alteration, it 
suggest that the Biofield Energy Treated test formulation and 
Biofield Energy Treatment per se (day -15) were found safe 
and non-toxic at the tested concentrations. 
Histopathological study analysis suggest that no treatment-
related histopathological alterations were reported in all the 
experimental animals compared with the normal control animal 
groups. Overall, the data of animal body weight and tested organ 
weight, its relative percentage showed no significant change. 
The literature suggest that organ body weight ratio is regarded as 
the useful index for the identification of swelling, atrophy, or 
hypertrophy [50]. It was assumed that after exposure of any 
formulation, if body weight and organ weight were increased in 
 Advances in Applied Physiology 2017; 2(1): 18-27 25 
 
the animals, then it was regarded as hypertrophy, while decrease 
in the relative weight indicated the atrophy. However, an 
increase in body weight and organ-body ratio can be directly 
correlated with the product toxicity, but our experimental data 
showed no significant change that depict non-toxic nature of the 
Biofield Energy Treated test formulation throughout the 
exposure period. 
3.6. Effect of the Test Formulation on Feed and Water 
Intake 
The feed and water intake were measured throughout the 
experiment and compared with different groups. The results 
suggested no statistically significant change throughout the 
experimental period compared with the normal control group 
(Table 5). It was observed that the animal feed and water 
intake in the disease control group was slightly higher 
compared with the other tested groups. Feed intake data 
suggests the mean value in the disease control (G2) was 26.00 
± 2.09 gm, while it was reported as 20.28 ± 1.61, 19.41 ± 2.42, 
21.44 ± 1.22, 23.42 ± 1.01, and 23.12 ± 1.86 gm in the G3, G4, 
G5, G6, and G7 groups, respectively. However, the change 
with respect to the disease control group was not statistically 
significant. Similarly, in case of water intake parameters, the 
data suggested that maximum water intake values (in mL) was 
in the disease control group (G2) i.e. 40.36 ± 2.52 mL, while it 
showed no significant change in other tested groups. 
Besides, the pretreatment data (day -14) of initial feed 
consumed (in grams) in group G1, G2, G6, and G7 were 
reported as 22.93 ± 1.12, 25.44 ± 0.79, 21.94 ± 1.02, and 
22.12 ± 1.00 gm respectively. However, the final (day -1) 
feed consumed (in grams) in all the groups were found non-
significant. Similarly, the pretreatment data (day -14) of 
water intake (in mL) in group G1, G2, G6, and G7 were 
found as 42.25 ± 2.68, 43.75 ± 2.40, 38.63 ± 2.36, and 45.25 
± 2.53 mL, respectively. However, the final (day -1) water 
intake data (in mL) in group G1, G2, G6, and G7 were 
observed as 38.64 ± 2.65, 40.24 ± 2.89, 34.14 ± 1.74, and 
35.16 ± 2.07 mL, respectively, which suggest no significant 
alteration among the tested groups. 
Overall, the effect of the Biofield Energy Treated test 
formulation, untreated test formulation, and Biofield Energy 
Treatment per se (day -15) did not show any significant 
change in the feed and water intake in male animals. 
Table 5. The effect of the test formulation on the feed and water intake in 
male rats. 
Group Feed Intake (gm) Water Intake (mL) 
G1 26.36 ± 1.14 39.59 ± 2.96 
G2 26.00 ± 2.09 40.36 ± 2.52 
G3 20.28 ± 1.61 39.66 ± 2.34 
G4 19.41 ± 2.42 35.47 ± 4.08 
G5 21.44 ± 1.22 36.82 ± 2.08 
G6 23.42 ± 1.01 37.11 ± 1.93 
G7 23.12 ± 1.86 39.59 ± 2.68 
G1: Normal Control; G2: Disease Control: G3: Levamisole; G4: Biofield 
Energy Treated test formulation; G5: Untreated test formulation; G6: Biofield 
Energy Treatment per se (day -15); G7: Biofield Energy Treated test 
formulation (day -15). All values are expressed as the mean ± SEM (n = 8). 
Overall, the study results of above experimental parameters 
suggested that the significant change in immunomodulatory 
parameters were due to the Biofield Energy Treatment per se, 
and Biofield Energy Treated test formulation with respect to 
the cellular and humoral immune responses along with 
improved hematological and biochemical parameters. It was 
suggested that The Trivedi Effect
®
- Energy of Consciousness 
Healing Treatment (Biofield Energy Healing Treatment) by the 
renowned Healing Practioners has the significant 
immunomodulatory action. These alteration might be due to 
the unique electromagnetic field or radiations of the Healers 
during the Biofield Energy Treatment. The Biofield Energy 
Treated test formulation is a new proprietary herbomineral 
formulation, which might be used to modulate the immune 
system and work as better approach in future against many 
autoimmune and antiinflammatory related disorders. However, 
the traditional medicines along with medicinal plants along 
with essential minerals can be considered as the powerful 
source of new drug moieties, and most of the world population 
depends upon the traditional medicine for health benefits in the 
developing world. 
4. Conclusions 
On the basis of experimental results, it can be concluded 
the significantly impact of The Trivedi Effect
®
-Energy of 
Consciousness Healing Treatment (Biofield Energy Healing 
Treatment) on test formulation exerts substantial anti-
inflammatory and immunomodulatory potential without any 
adverse effect at all the tested concentrations. The humoral 
immune response data showed the primary and secondary 
antibody titre were increased by 26% and 150.4%, 
respectively in the Biofield Energy Treatment per se group 
(G6, day -15), while in the Biofield Energy Treated test 
formulation (G7, day -15) showed an increased primary and 
secondary antibody titre values by 100% and 110.4%, 
respectively compared with the disease control group (G2). 
Further, a delayed type hypersensitivity data suggests that the 
Biofield Energy Treated test formulation (G4) group showed 
a significant increased paw volume by 94.44% with respect 
to the G2 group. In addition, G6 and G7 groups showed a 
significant increased paw edema by 61.11% and 44.44%, 
respectively with respect to the G2 group. Hematology 
profile after treatment with the Biofield Energy Treated test 
formulation showed a significant (p<0.001) increase in the 
platelet count by 85.60% in the G4 group compared with the 
G2 group. However, the Biofield Energy Treatment per se 
(G6) and Biofield Energy Treated test formulation (G7) also 
showed an increase in the platelet count by 39.15% and 
35.22%, respectively, compared with the G2 group. In serum 
biochemistry, a significant increase in calcium and 
phosphorus levels was reported, with respect to the disease 
control group. However, no treatment-related changes were 
observed in any group with respect to body weight, feed 
intake, and water intake data in the Biofield Energy Treated 
test formulation and Biofield Energy Treatment per se groups 
during the course of the experiment. Therefore, The Trivedi 
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Effect
®
- Energy of Consciousness Healing Treatment 
(Biofield Energy Healing Treatment) administered remotely 
by the seven Biofield Energy Healers enhanced the 
herbomineral test formulation’s anti-inflammatory and 
immunomodulatory properties without any toxic effect to the 
animals throughout the exposure period. Thus, the Biofield 
Energy Treated test formulation and Biofield Energy 
Treatment per se in male rats showed an effective anti-
inflammatory and immunomodulatory action, and it can be 
used as a Complementary and Alternative Medicine (CAM) 
with a safe therapeutic index for various autoimmune 
disorders such as Lupus, Systemic Lupus Erythematosus, 
Fibromyalgia, Addison Disease, Hashimoto Thyroiditis, 
Celiac Disease (gluten-sensitive enteropathy), Multiple 
Sclerosis, Dermatomyositis, Graves’ Disease, Myasthenia 
Gravis, Pernicious Anemia, Aplastic Anemia, Scleroderma, 
Psoriasis, Rheumatoid Arthritis, Reactive Arthritis, Type 1 
Diabetes, Sjogren Syndrome, Crohn’s Disease, Vasculitis, 
Vitiligo, Chronic Fatigue Syndrome and Alopecia Areata, as 
well as inflammatory disorders such as Irritable Bowel 
Syndrome (IBS), Asthma, Ulcerative Colitis, Alzheimer’s 
Disease, Parkinson’s Disease, Atherosclerosis, Dermatitis, 
Hepatitis, and Diverticulitis. Further, the Biofield Energy 
Healing Treated test formulation can also be used in the 
prevention of immune-mediated tissue damage in cases of 
organ transplants (for example heart transplants, kidney 
transplants and liver transplants), for anti-aging, stress 
prevention and management, and in the improvement of 
overall health and quality of life. 
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